Abstract
Currently more and more high-throughput biotechnologies have been armed by immunologists to explore the pathological mechanism of different autoimmune diseases. The new wave of approaches for the integrated understanding of human immune system based on high-throughput methods, corresponding mathematical and computational tools are increasing. This paper described the combination tendency of multiple methods to investigate the whole immune process at different levels including transcription, translation and post-translation modification, using microarray, Luminex and CyTOF as an example. When proper high-throughput technologies were used in combination, there will be more comprehensive recognition on immune system. The application of such techniques will promote deeper and more integrated study in the immunization field, and become a promising study strategy in this field.
Keywords: Autoimmune disease (AID), CyTOF, high-throughput, luminex, microarray, multiplex high-throughput biotechnologies.
Current Pharmaceutical Analysis
Title:Combinatorial Application of Multiple High-throughput Biotechnologies for the Study of Autoimmune Diseases
Volume: 11 Issue: 3
Author(s): Yiping Xun, Guangyu Chen and Hongwu Du
Affiliation:
Keywords: Autoimmune disease (AID), CyTOF, high-throughput, luminex, microarray, multiplex high-throughput biotechnologies.
Abstract: Currently more and more high-throughput biotechnologies have been armed by immunologists to explore the pathological mechanism of different autoimmune diseases. The new wave of approaches for the integrated understanding of human immune system based on high-throughput methods, corresponding mathematical and computational tools are increasing. This paper described the combination tendency of multiple methods to investigate the whole immune process at different levels including transcription, translation and post-translation modification, using microarray, Luminex and CyTOF as an example. When proper high-throughput technologies were used in combination, there will be more comprehensive recognition on immune system. The application of such techniques will promote deeper and more integrated study in the immunization field, and become a promising study strategy in this field.
Export Options
About this article
Cite this article as:
Xun Yiping, Chen Guangyu and Du Hongwu, Combinatorial Application of Multiple High-throughput Biotechnologies for the Study of Autoimmune Diseases, Current Pharmaceutical Analysis 2015; 11 (3) . https://dx.doi.org/10.2174/1573412911666150121233916
DOI https://dx.doi.org/10.2174/1573412911666150121233916 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
NF-κB in Type 1 Diabetes
Inflammation & Allergy - Drug Targets (Discontinued) Deciphering the Antibodyome - Peptide Arrays for Serum Antibody Biomarker Diagnostics
Current Proteomics Models of Antigen Receptor Activation in the Design of Vaccines
Current Pharmaceutical Design The Cancer Hygiene Hypothesis: From Theory to Therapeutic Helminths
Current Cancer Therapy Reviews Review of Recent Clinical Developments and Patents for the Treatment of Autoimmune and Inflammatory Diseases by Mesenchymal Stromal Cells
Recent Patents on Regenerative Medicine Comparative Biochemistry of GH3, GH20 and GH84 β-N-acetyl-Dhexosaminidases and Recent Progress in Selective Inhibitor Discovery
Current Drug Targets Interleukin-7: a key Mediator in T Cell-driven Autoimmunity, Inflammation, and Tissue Destruction
Current Pharmaceutical Design Cytokines as Novel Therapeutic Agents for Neuroinflammatory Disorders: A Role for Interferon-β in the Treatment of Multiple Sclerosis
Current Medicinal Chemistry - Central Nervous System Agents Cytokine Gene Polymorphism in Heart Transplantation: A Review
Current Genomics An Update on Autoinflammatory Diseases
Current Medicinal Chemistry Neuropeptides as Therapeutic Approach to Autoimmune Diseases
Current Pharmaceutical Design Autoimmunity and Apoptosis - Therapeutic Implications
Current Medicinal Chemistry The Impact of Fc Receptors on the Development of Autoimmune Diseases
Current Pharmaceutical Design Microbes, Immunity and Multiple Sclerosis: An Update
Current Immunology Reviews (Discontinued) B Cells and Beyond: Therapeutic Opportunities Targeting Inflammation
Inflammation & Allergy - Drug Targets (Discontinued) Impact of Hydroxyl Radical Modified-Human Serum Albumin Autoantigens in Systemic Lupus Erythematosus
Current Protein & Peptide Science Approaches to the Pharmacological Modulation of Plasmacytoid Dendritic Cells
Endocrine, Metabolic & Immune Disorders - Drug Targets Regulation of B Cell Activation by PECAM-1: Implications for the Development of Autoimmune Disorders
Current Pharmaceutical Design One Special Question to Start with: Can HIF/NFkB be a Target in Inflammation?
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Characteristics of Autoimmune Pancreatitis
Current Pharmaceutical Design